Promethazine theoclate is a combination of promethazine, an antihistamine, and theoclate, a derivative of theophylline. It is used for its antihistaminic, antiemetic, and sedative properties. It helps in relieving symptoms associated with allergies, nausea, and motion sickness.
Promethazine theoclate is used for:
| Brand Name | Promethazine Theoclate |
|---|---|
| Type | |
| Weight | |
| Generic | Promethazine Theoclate |
| Manufacturer | |
| Available in | English বাংলা |
Promethazine works by blocking histamine H1 receptors, which alleviates allergic symptoms and reduces nausea. The theoclate component has a mild bronchodilator effect and improves airflow, which can help with respiratory symptoms associated with allergies.
Promethazine theoclate typically begins to work within 30 minutes to 1 hour after oral administration. The peak effect is usually observed within 1-2 hours, depending on the individual's metabolism and the severity of symptoms.
Promethazine is well absorbed from the gastrointestinal tract, with peak plasma concentrations occurring within 1-2 hours after oral administration. The absorption rate of theoclate is also rapid, contributing to the overall effectiveness of the combination.
Promethazine is metabolized in the liver and excreted primarily through the urine. Theoclate is also metabolized in the liver, with elimination occurring through both urine and feces.
The dosage of promethazine theoclate depends on the specific condition being treated and patient factors:
Dosage may need to be adjusted based on individual response and tolerability.
Promethazine theoclate is administered orally, typically in the form of tablets. It should be taken with water, and it is important to follow the prescribed dosage regimen for optimal effectiveness.
Common side effects include:
Serious side effects can include severe allergic reactions, difficulty breathing, and severe drowsiness. Seek medical attention if any severe side effects occur.
Toxicity may result from an overdose and can manifest as extreme drowsiness, confusion, or hallucinations. If overdose is suspected, seek immediate medical attention. Treatment involves supportive care and monitoring.
Precautions include:
Promethazine theoclate can interact with other central nervous system depressants, such as alcohol and benzodiazepines, leading to enhanced sedative effects. It may also interact with other medications metabolized by the liver.
Use with caution in patients with liver disease, respiratory conditions, or history of seizures. Regular monitoring may be necessary to adjust the dosage and manage any potential adverse effects.
Drug interactions may occur with other medications that affect the central nervous system or liver metabolism. It's important to inform healthcare providers of all current medications to prevent potential interactions.
There are no specific food interactions reported with promethazine theoclate. However, it is advisable to avoid alcohol and other sedative substances to prevent enhanced sedative effects.
Promethazine theoclate is categorized as a Category C drug for pregnancy. It should be used during pregnancy only if the potential benefits outweigh the risks. Consult a healthcare provider for appropriate use during pregnancy.
Promethazine is excreted in breast milk, and the effects on a nursing infant are not fully known. Use with caution while breastfeeding, and consult with a healthcare provider regarding the safety of breastfeeding while on this medication.
Symptoms of acute overdose include severe drowsiness, confusion, and potentially life-threatening reactions such as respiratory depression. Seek immediate medical attention if overdose is suspected. Treatment focuses on supportive care and symptomatic management.
Promethazine theoclate is contraindicated in patients with known hypersensitivity to promethazine or theoclate. It should be avoided in patients with severe respiratory conditions or acute asthma attacks.
Take promethazine theoclate exactly as prescribed by a healthcare provider. Adhere to the dosing schedule and avoid taking more than the recommended dose. Consult with a healthcare provider for any adjustments or if symptoms persist.
Store promethazine theoclate at room temperature, away from moisture and heat. Keep the medication in its original container, tightly closed, and out of reach of children.
The volume of distribution for promethazine theoclate is not specifically documented but generally reflects the distribution of its individual components in the body.
The half-life of promethazine is approximately 10-19 hours, while the half-life of theoclate can vary. The combined half-life of promethazine theoclate may be influenced by the metabolism and excretion rates of both components.
Promethazine is primarily cleared through the liver and kidneys. The clearance rate of theoclate also involves liver metabolism and renal excretion. Clearance may be affected by liver and kidney function, necessitating adjustments in dosage as needed.
See in details version Promethazine Theoclate also Promethazine Theoclate in bangla
Prof. Dr. Nadira Begum
Gynecology, Obstetrics, Infertility Specialist & Laparoscopic Surgeon